A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -71.08% this year. Over the last six months, there has been a stronger performance of -25.52%. The price of MED fallen by 5.02% during the last 30 days period. For the last 5-days stocks have improved 7.05%.
Medifast Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $76.42 on 12/12/23, while the lowest value for the same period was recorded at $17.07 on 10/15/24.
52-week price history of MED Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Medifast Inc’s current trading price is -74.56% away from its 52-week high, while its distance from the 52-week low is 13.89%. The stock’s price range during this period has varied between$17.07 and $76.42. The Medifast Inc’s shares, which operate in the Consumer Cyclical, saw a trading volume of around 0.26 million for the day, a figure considerably higher than their average daily volume of 0.19 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Medifast Inc (MED) has experienced a quarterly rise of 4.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 212.63M and boasts a workforce of 634 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.89, with a change in price of +1.03. Similarly, Medifast Inc recorded 244,208 in trading volume during the last 100 days, posting a change of +5.59%.
MED’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MED stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.
MED Stock Stochastic Average
As of today, Medifast Inc’s raw stochastic average for the last 50 days stands at 59.11%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 59.10%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 42.98% and 37.21%, respectively.
